Avidity Partners Management LP 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 10:02 am Unchanged |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
Avidity Partners Management LP | 7,776,296 9.900% |
0 (Unchanged) |
Filing |
2024-11-14 5:31 pm Unchanged |
2024-09-30 | 13G | Context Therapeutics Inc. CNTX |
Avidity Partners Management LP | 7,776,296 9.900% |
0 (Unchanged) |
Filing |
2024-05-13 10:37 am Purchase |
2024-05-02 | 13G | Context Therapeutics Inc. CNTX |
Avidity Partners Management LP | 7,776,296 9.900% |
7,776,296![]() (New Position) |
Filing |